GlassScriptPhysician profile
Samantha W Geweke
NPI 1992719322
$1,143.41
in general payments reported to CMS, 2019-2025
17 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $254 · 2023: $61.24 · 2024: $308 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $219.17 | 2021-2024 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $212.66 | 2021-2025 | Jublia, Cabtreo |
| Abbvie INC. | $151.65 | 2021-2025 | |
| Incyte Corporation | $72.43 | 2022-2024 | Opzelura |
| Leo Pharma INC. | $72.41 | 2024-2025 | Adbry, Anzupgo |
| Lilly USA, LLC | $69.95 | 2021-2024 | Taltz |
| Pfizer INC. | $51.24 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $49.88 | 2025 | Sotyktu |
| Ucb, INC. | $49.36 | 2022-2025 | Bimzelx |
| Organon LLC | $38.98 | 2025 | Vtama |
| Novartis Pharmaceuticals Corporation | $37.96 | 2025 | |
| Sun Pharmaceutical Industries INC. | $37.13 | 2023-2025 | Absorica Ld, Winlevi |
| Epi Health, LLC | $18.97 | 2021 | |
| Genzyme Corporation | $17.08 | 2021 | |
| Arcutis Biotherapeutics, INC. | $16.07 | 2024 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $14.36 | 2025 | |
| Amgen INC. | $14.11 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Geweke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.